References
1. Katz RM. Rhinitis in the athlete. J Allergy Clin Immunol. 1984;73(5
Pt 2):708-11.
2. Spence L, Brown WJ, Pyne DB, Nissen MD, Sloots TP, McCormack JG, et
al. Incidence, etiology, and symptomatology of upper respiratory illness
in elite athletes. Medicine and science in sports and exercise.
2007;39(4):577-86.
3. Walker AC, Surda P, Rossiter M, Little SA. Nasal disease and quality
of life in athletes. J Laryngol Otol. 2018;132(9):812-5.
4. Bougault V, Turmel J, Boulet LP. Effect of intense swimming training
on rhinitis in high-level competitive swimmers. ClinExpAllergy.
2010;40(8):1238-46.
5. Steelant B, Hox V, Van Gerven L, Dilissen E, Dekimpe E, Kasran A, et
al. Nasal symptoms, epithelial injury and neurogenic inflammation in
elite swimmers. Rhinology. 2018;56(3):279-87.
6. Classifying recommendations for clinical practice guidelines.
Pediatrics. 2004;114(3):874-7.
7. Wang de Y, Lee HP, Gordon BR. Impacts of fluid dynamics simulation in
study of nasal airflow physiology and pathophysiology in realistic human
three-dimensional nose models. Clinical and experimental
otorhinolaryngology. 2012;5(4):181-7.
8. Recinto C, Efthemeou T, Boffelli PT, Navalta JW. Effects of Nasal or
Oral Breathing on Anaerobic Power Output and Metabolic Responses.
International journal of exercise science. 2017;10(4):506-14.
9. Meir R, Zhao GG, Zhou S, Beavers R, Davie A. The acute effect of
mouth only breathing on time to completion, heart rate, rate of
perceived exertion, blood lactate, and ventilatory measures during a
high-intensity shuttle run sequence. Journal of strength and
conditioning research. 2014;28(4):950-7.
10. Campbell AP, Hoehle LP, Phillips KM, Caradonna DS, Gray ST, Sedaghat
AR. Depressed mood is associated with loss of productivity in allergic
rhinitis. Allergy. 2018;73(5):1141-4.
11. Canonica GW, Mullol J, Pradalier A, Didier A. Patient perceptions of
allergic rhinitis and quality of life: findings from a survey conducted
in europe and the United States. The World Allergy Organization journal.
2008;1(9):138-44.
12. Khan A, Huynh TMT, Vandeplas G, Joish VN, Mannent LP, Tomassen P, et
al. The GALEN rhinosinusitis cohort: chronic rhinosinusitis with nasal
polyps affects health-related quality of life. Rhinology.
2019;57(5):343-51.
13. Katelaris CH, Carrozzi FM, Burke TV, Byth K. A springtime olympics
demands special consideration for allergic athletes. J Allergy Clin
Immunol. 2000;106(2):260-6.
14. Walker A, Surda P, Rossiter M, Little S. Rhinitis in Elite and
Non-Elite Field Hockey Players. International journal of sports
medicine. 2017;38(1):65-70.
15. Surda P, Putala M, Siarnik P, Walker A, Bernic A, Fokkens W.
Rhinitis and its impact on quality of life in swimmers. Allergy.
2018;73(5):1022-31.
16. Salem L, Dao VA, Shah-Hosseini K, de Marees M, Mester J, Mosges R,
et al. Impaired sports performance of athletes suffering from
pollen-induced allergic rhinitis: a cross-sectional, observational
survey in German athletes. The Journal of sports medicine and physical
fitness. 2019;59(4):686-92.
17. Silvers WS, Poole JA. Exercise-induced rhinitis: a common disorder
that adversely affects allergic and nonallergic athletes. Annals of
allergy, asthma & immunology : official publication of the American
College of Allergy, Asthma, & Immunology. 2006;96(2):334-40.
18. Roxbury CR, Qiu M, Shargorodsky J, Lin SY. Association between
allergic rhinitis and poor sleep parameters in U.S. adults. Int Forum
Allergy Rhinol. 2018;8(10):1098-106.
19. Watson AM. Sleep and Athletic Performance. Curr Sports Med Rep.
2017;16(6):413-8.
20. Bousquet J, Khaltaev N, Cruz AA, Denburg J, Fokkens WJ, Togias A, et
al. Allergic Rhinitis and its Impact on Asthma (ARIA) 2008 update (in
collaboration with the World Health Organization, GA(2)LEN and
AllerGen). Allergy. 2008;63 Suppl 86:8-160.
21. Fokkens WJ, Lund VJ, Mullol J, Bachert C, Alobid I, Baroody F, et
al. EPOS 2012: European position paper on rhinosinusitis and nasal
polyps 2012. A summary for otorhinolaryngologists. Rhinology.
2012;50(1):1-12.
22. Reeser JC, Willick S, Elstad M. Medical services provided at the
Olympic Village polyclinic during the 2002 Salt Lake City Winter Games.
WMJ : official publication of the State Medical Society of Wisconsin.
2003;102(4):20-5.
23. Robinson SR, Wormald PJ. Endoscopic vidian neurectomy. American
journal of rhinology. 2006;20(2):197-202.
24. Nieman DC, Johanssen LM, Lee JW, Arabatzis K. Infectious episodes in
runners before and after the Los Angeles Marathon. The Journal of sports
medicine and physical fitness. 1990;30(3):316-28.
25. Gleeson M, Pyne DB, Austin JP, Lynn Francis J, Clancy RL, McDonald
WA, et al. Epstein-Barr virus reactivation and upper-respiratory illness
in elite swimmers. Medicine and science in sports and exercise.
2002;34(3):411-7.
26. Makela MJ, Puhakka T, Ruuskanen O, Leinonen M, Saikku P, Kimpimaki
M, et al. Viruses and bacteria in the etiology of the common cold. J
Clin Microbiol. 1998;36(2):539-42.
27. Peters EM, Bateman ED. Ultramarathon running and upper respiratory
tract infections. An epidemiological survey. S Afr Med J.
1983;64(15):582-4.
28. Peters EM, Shaik J, Kleinveldt N. Upper respiratory tract infection
symptoms in ultramarathon runners not related to immunoglobulin status.
Clinical journal of sport medicine : official journal of the Canadian
Academy of Sport Medicine. 2010;20(1):39-46.
29. Walsh NP, Gleeson M, Shephard RJ, Gleeson M, Woods JA, Bishop NC, et
al. Position statement. Part one: Immune function and exercise. Exercise
immunology review. 2011;17:6-63.
30. Greiner AN, Hellings PW, Rotiroti G, Scadding GK. Allergic rhinitis.
Lancet. 2011;378(9809):2112-22.
31. Surda P, Walker A, Limpens J, Fokkens W, Putala M. Nasal changes
associated with exercise in athletes: systematic review. J Laryngol
Otol. 2018;132(3):191-7.
32. Surda P, Walker A, Putala M, Siarnik P. Prevalence of Rhinitis in
Athletes: Systematic Review. Int J Otolaryngol. 2017;2017:8098426.
33. Bernard A, Nickmilder M, Voisin C, Sardella A. Impact of chlorinated
swimming pool attendance on the respiratory health of adolescents.
Pediatrics. 2009;124(4):1110-8.
34. Hox V, Vanoirbeek JA, Alpizar YA, Voedisch S, Callebaut I, Bobic S,
et al. Crucial role of transient receptor potential ankyrin 1 and mast
cells in induction of nonallergic airway hyperreactivity in mice. Am J
Respir Crit Care Med. 2013;187(5):486-93.
35. Lakier Smith L. Overtraining, excessive exercise, and altered
immunity: is this a T helper-1 versus T helper-2 lymphocyte response?
Sports Med. 2003;33(5):347-64.
36. Steensberg A, Toft AD, Bruunsgaard H, Sandmand M,
Halkjaer-Kristensen J, Pedersen BK. Strenuous exercise decreases the
percentage of type 1 T cells in the circulation. J Appl Physiol (1985).
2001;91(4):1708-12.
37. Bachert C, Van Cauwenberghe P, Olbrecht J, Van Schoor J. Prevalence,
Classification and Perception of Allergic and Non-allergic Rhinitis.
Allergy. 2006;61(6):693-8.
38. Gelardi M, Ventura MT, Fiorella R, Fiorella ML, Russo C, Candreva T,
et al. Allergic and non-allergic rhinitis in swimmers: clinical and
cytological aspects. Br J Sports Med. 2012;46(1):54-8.
39. Ottaviano G, Staffieri A, Stritoni P, Ermolao A, Coles S, Zaccaria
M, et al. Nasal dysfunction induced by chlorinate water in competitive
swimmers. Rhinology. 2012;50(3):294-8.
40. Cavalcante de Sa M, Nakagawa NK, Saldiva de Andre CD,
Carvalho-Oliveira R, de Santana Carvalho T, Nicola ML, et al. Aerobic
exercise in polluted urban environments: effects on airway defense
mechanisms in young healthy amateur runners. Journal of breath research.
2016;10(4):046018.
41. Santos J, Foster R, Jonckheere AC, Rossi M, Luna Junior LA, Katekaru
CM, et al. Outdoor Endurance Training with Air Pollutant Exposure Versus
Sedentary Lifestyle: A Comparison of Airway Immune Responses.
International journal of environmental research and public health.
2019;16(22).
42. Baraniuk JN, Merck SJ. Nasal reflexes: implications for exercise,
breathing, and sex. Current allergy and asthma reports.
2008;8(2):147-53.
43. Jones AS. Autonomic reflexes and non-allergic rhinitis. Allergy.
1997;52(36 Suppl):14-9.
44. Muns G, Rubinstein I, Singer P. Neutrophil chemotactic activity is
increased in nasal secretions of long-distance runners. International
journal of sports medicine. 1996;17(1):56-9.
45. Doulaptsi M, Steelant B, Prokopakis E, Ierodiakonou D, Tsinaslanidou
Z, Cools L, et al. Prevalence and impact of nasal hyperreactivity in
chronic rhinosinusitis. Allergy. 2020.
46. Van Gerven L, Steelant B, Hellings PW. Nasal hyperreactivity in
rhinitis: A diagnostic and therapeutic challenge. Allergy. 2018.
47. Van Gerven L, Boeckxstaens G, Jorissen M, Fokkens W, Hellings PW.
Short-time cold dry air exposure: a useful diagnostic tool for nasal
hyperresponsiveness. Laryngoscope. 2012;122(12):2615-20.
48. Bonadonna P, Senna G, Zanon P, Cocco G, Dorizzi R, Gani F, et al.
Cold-induced rhinitis in skiers–clinical aspects and treatment with
ipratropium bromide nasal spray: a randomized controlled trial. American
journal of rhinology. 2001;15(5):297-301.
49. Sonmez G, Uzun G, Mutluoglu M, Toklu AS, Mutlu H, Ay H, et al.
Paranasal sinus mucosal hypertrophy in experienced divers. Aviation,
space, and environmental medicine. 2011;82(10):992-4.
50. Fischer H, Gubisch W. Nasal valves–importance and surgical
procedures. Facial plastic surgery : FPS. 2006;22(4):266-80.
51. Chen XB, Lee HP, Chong VF, Wang de Y. Impact of inferior turbinate
hypertrophy on the aerodynamic pattern and physiological functions of
the turbulent airflow - a CFD simulation model. Rhinology.
2010;48(2):163-8.
52. Passàli D, Damiani V, Passàli GC, Passàli FM, Bellussi L.
Alterations in rhinosinusal homeostasis in a sportive population: our
experience with 106 athletes. European archives of oto-rhino-laryngology
: official journal of the European Federation of
Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German
Society for Oto-Rhino-Laryngology - Head and Neck Surgery.
2004;261(9):502-6.
53. Hellings PW, Scadding G, Alobid I, Bachert C, Fokkens WJ, Gerth van
Wijk R, et al. Executive summary of European Task Force document on
diagnostic tools in rhinology. Rhinology. 2012;50(4):339-52.
54. Hamilton GS, 3rd. The External Nasal Valve. Facial plastic surgery
clinics of North America. 2017;25(2):179-94.
55. Ottaviano G, Fokkens WJ. Measurements of nasal airflow and patency:
a critical review with emphasis on the use of peak nasal inspiratory
flow in daily practice. Allergy. 2016;71(2):162-74.
56. Bonini S, Bonini M, Bousquet J, Brusasco V, Canonica GW, Carlsen KH,
et al. Rhinitis and asthma in athletes: an ARIA document in
collaboration with GA2LEN. Allergy. 2006;61(6):681-92.
57. Jonckheere AC, Seys SF, Dilissen E, Marijsse G, Schelpe AS, Van der
Eycken S, et al. AQUA((c)) Questionnaire as prediction tool for atopy in
young elite athletes. Pediatric allergy and immunology : official
publication of the European Society of Pediatric Allergy and Immunology.
2018;29(6):648-50.
58. Brozek JL, Bousquet J, Baena-Cagnani CE, Bonini S, Canonica GW,
Casale TB, et al. Allergic Rhinitis and its Impact on Asthma (ARIA)
guidelines: 2010 revision. J Allergy Clin Immunol. 2010;126(3):466-76.
59. Auge J, Vent J, Agache I, Airaksinen L, Campo Mozo P, Chaker A, et
al. EAACI Position paper on the standardization of nasal allergen
challenges. Allergy. 2018;73(8):1597-608.
60. Hellings PW, Klimek L, Cingi C, Agache I, Akdis C, Bachert C, et al.
Non-allergic rhinitis: Position paper of the European Academy of Allergy
and Clinical Immunology. Allergy. 2017;72(11):1657-65.
61. World anti-doping code, (2020).
62. Santos A CM, Delgado L. Best buys for allergic rhinitis and chronic
rhinosinusitis prevention and control. In: Akdis CA HP, Agache I,
editor. Global atlas of allergic rhinitis and chronic rhinosinusitis:
European Academy of Allergy and Clinical Immunology; 2015.
63. Fantuzzi G, Righi E, Predieri G, Giacobazzi P, Petra B, Aggazzotti
G. Airborne trichloramine (NCl(3)) levels and self-reported health
symptoms in indoor swimming pool workers: dose-response relationships.
Journal of exposure science & environmental epidemiology.
2013;23(1):88-93.
64. Seys SF, Feyen L, Keirsbilck S, Adams E, Dupont LJ, Nemery B. An
outbreak of swimming-pool related respiratory symptoms: An elusive
source of trichloramine in a municipal indoor swimming pool.
International journal of hygiene and environmental health.
2015;218(4):386-91.
65. WHO. Guidelines for safe recreational water environments. Volume 2,
Swimming pools and similar environments. In: Organization WH, editor.
2006.
66. Katelaris CH, Carrozzi FM, Burke TV, Byth K. Effects of intranasal
budesonide on symptoms, quality of life, and performance in elite
athletes with allergic rhinoconjunctivitis. Clinical journal of sport
medicine : official journal of the Canadian Academy of Sport Medicine.
2002;12(5):296-300.
67. Hox V, Lourijsen E, Jordens A, Aasbjerg K, Agache I, Alobid I, et
al. Benefits and harm of systemic steroids for short- and long-term use
in rhinitis and rhinosinusitis: an EAACI position paper. Clinical and
translational allergy. 2020;10:1.
68. Simons FE. Advances in H1-antihistamines. The New England journal of
medicine. 2004;351(21):2203-17.
69. Banov CH, Lieberman P, Vasomotor Rhinitis Study G. Efficacy of
azelastine nasal spray in the treatment of vasomotor (perennial
nonallergic) rhinitis. Annals of allergy, asthma & immunology :
official publication of the American College of Allergy, Asthma, &
Immunology. 2001;86(1):28-35.
70. Gehanno P, Deschamps E, Garay E, Baehre M, Garay RP. Vasomotor
rhinitis: clinical efficacy of azelastine nasal spray in comparison with
placebo. ORL J Otorhinolaryngol Relat Spec. 2001;63(2):76-81.
71. Price D, Shah S, Bhatia S, Bachert C, Berger W, Bousquet J, et al. A
new therapy (MP29-02) is effective for the long-term treatment of
chronic rhinitis. Journal of investigational allergology & clinical
immunology. 2013;23(7):495-503.
72. Kortekaas Krohn I, Callebaut I, Alpizar YA, Steelant B, Van Gerven
L, Skov PS, et al. MP29-02 reduces nasal hyperreactivity and nasal
mediators in patients with house dust mite-allergic rhinitis. Allergy.
2018;73(5):1084-93.
73. Farre M, Perez-Mana C, Papaseit E, Menoyo E, Perez M, Martin S, et
al. Bilastine vs. hydroxyzine: occupation of brain histamine H1
-receptors evaluated by positron emission tomography in healthy
volunteers. British journal of clinical pharmacology. 2014;78(5):970-80.
74. Passalacqua G, Bousquet J, Bachert C, Church MK, Bindsley-Jensen C,
Nagy L, et al. The clinical safety of H1-receptor antagonists. An EAACI
position paper. Allergy. 1996;51(10):666-75.
75. Philip G, Nayak AS, Berger WE, Leynadier F, Vrijens F, Dass SB, et
al. The effect of montelukast on rhinitis symptoms in patients with
asthma and seasonal allergic rhinitis. Current medical research and
opinion. 2004;20(10):1549-58.
76. Roberts G, Pfaar O, Akdis CA, Ansotegui IJ, Durham SR, Gerth van
Wijk R, et al. EAACI Guidelines on Allergen Immunotherapy: Allergic
rhinoconjunctivitis. Allergy. 2018;73(4):765-98.
77. Lekakis G, Dekimpe E, Steelant B, Hellings PW. Managing nasal valve
compromise patients with nasal dilators: objective vs. subjective
parameters. Rhinology. 2016;54(4):348-54.
78. Dinardi RR, de Andrade CR, Ibiapina Cda C. External nasal dilators:
definition, background, and current uses. International journal of
general medicine. 2014;7:491-504.
79. Gelardi M, Porro G, Accettura D, Quaranta VN, Quaranta N, Ciprandi
G. The role of an internal nasal dilator in athletes. Acta bio-medica :
Atenei Parmensis. 2019;90(2-s).
80. Tong TK, Fu FH, Chow BC. Nostril dilatation increases capacity to
sustain moderate exercise under nasal breathing condition. The Journal
of sports medicine and physical fitness. 2001;41(4):470-8.
81. Ottaviano G, Ermolao A, Nardello E, Muci F, Favero V, Zaccaria M, et
al. Breathing parameters associated to two different external nasal
dilator strips in endurance athletes. Auris, nasus, larynx.
2017;44(6):713-8.
82. Dinardi RR, de Andrade CR, Ibiapina Cda C. Evaluation of the
effectiveness of the external nasal dilator strip in adolescent
athletes: a randomized trial. International journal of pediatric
otorhinolaryngology. 2013;77(9):1500-5.
83. van Egmond M, Rovers MM, Tillema AHJ, van Neerbeek N. Septoplasty
for nasal obstruction due to a deviated nasal septum in adults: a
systematic review. Rhinology. 2018;56(3):195-208.
84. Lennon P, Jaber S, Fenton JE. Functional and psychological impact of
nasal bone fractures sustained during sports activities: A survey of 87
patients. Ear, nose, & throat journal. 2016;95(8):324-32.
85. Bonini M, Bachert C, Baena-Cagnani CE, Bedbrook A, Brozek JL,
Canonica GW, et al. What we should learn from the London Olympics. Curr
Opin Allergy Clin Immunol. 2013;13(1):1-3.
86. Hellings PW, Fokkens WJ, Bachert C, Akdis CA, Bieber T, Agache I, et
al. Positioning the principles of precision medicine in care pathways
for allergic rhinitis and chronic rhinosinusitis - A
EUFOREA-ARIA-EPOS-AIRWAYS ICP statement. Allergy. 2017;72(9):1297-305.
87. Hens G, Hellings PW. The nose: gatekeeper and trigger of bronchial
disease. Rhinology. 2006;44(3):179-87.
88. Stickland MK, Rowe BH, Spooner CH, Vandermeer B, Dryden DM. Effect
of warm-up exercise on exercise-induced bronchoconstriction. Medicine
and science in sports and exercise. 2012;44(3):383-91.
89. Seys SF, Bousquet J, Bachert C, Fokkens WJ, Agache I,
Bernal-Sprekelsen M, et al. mySinusitisCoach: patient empowerment in
chronic rhinosinusitis using mobile technology. Rhinology.
2018;56(3):209-15.